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Abstract: Rats are a reservoir of human- and livestock-associated methicillin-resistant
Staphylococcus aureus (MRSA). However, the composition of the natural S. aureus population in
wild and laboratory rats is largely unknown. Here, 144 nasal S. aureus isolates from free-living wild
rats, captive wild rats and laboratory rats were genotyped and profiled for antibiotic resistances
and human-specific virulence genes. The nasal S. aureus carriage rate was higher among wild rats
(23.4%) than laboratory rats (12.3%). Free-living wild rats were primarily colonized with isolates
of clonal complex (CC) 49 and CC130 and maintained these strains even in husbandry. Moreover,
upon livestock contact, CC398 isolates were acquired. In contrast, laboratory rats were colonized
with many different S. aureus lineages—many of which are commonly found in humans. Five captive
wild rats were colonized with CC398-MRSA. Moreover, a single CC30-MRSA and two CC130-MRSA
were detected in free-living or captive wild rats. Rat-derived S. aureus isolates rarely harbored the
phage-carried immune evasion gene cluster or superantigen genes, suggesting long-term adaptation
to their host. Taken together, our study revealed a natural S. aureus population in wild rats, as well as
a colonization pressure on wild and laboratory rats by exposure to livestock- and human-associated
S. aureus, respectively.
Keywords: Staphylococcus aureus; rat; clonal complex; host adaptation; livestock; laboratory;
coagulation; immune evasion cluster; habitat; epidemiology
Key Contribution: Wild rats harbor a specific Staphylococcus aureus population, but also acquire
livestock- and human-derived S. aureus strains, including MRSA, upon exposure. In contrast,
laboratory rats are colonized with a diverse set of S. aureus lineages—many of which are commonly
found in humans.
1. Introduction
Staphylococcus aureus (S. aureus) is a major opportunistic pathogen in human medicine and it
is increasingly recognized as a zoonotic pathogen. The nasal cavity of approximately 20% of adult
humans is persistently and asymptomatically colonized with S. aureus [1–3]. These bacteria can cause a
wide variety of illnesses, ranging from skin and soft tissue infections (e.g., abscesses) to life-threatening
diseases (e.g., endocarditis and sepsis) [4]. The emergence of multiresistant (methicillin-resistant
S. aureus, MRSA; vancomycin-resistant S. aureus, VRSA) and highly virulent (community acquired
MRSA, CA-MRSA) strains makes S. aureus a prominent example of the antibiotic resistance crisis and a
major public health concern worldwide [5–7]. This medical predicament is especially heightened by
the fact that to date, no S. aureus vaccine is available [8].
Besides humans, S. aureus is also able to colonize and infect numerous other species, including
companion animals, livestock as well as wild animals [9–13]. Transmission of MRSA occurs primarily
upon person-to-person contact, but MRSA can also spread between domestic animals and people [14,15].
The recent detection of MRSA in rats suggests that pest animals might be an additional reservoir for
MRSA [16–20]. For instance, wild rats caught on farms were carrying typical livestock-associated
(LA)-MRSA strains (e.g., clonal complex (CC) 398 and sequence type (ST) 97) [18,21], while urban
rats carried the same MRSA lineages prevalent in the respective local human or animal population
(e.g., USA300-ST8) [19]. The natural S. aureus population in rats, which is likely dominated by
methicillin-susceptible S. aureus (MSSA), is largely unknown [21]. In view of the emerging zoonotic
potential of certain S. aureus lineages [22–24], an effective “One Health” strategy against the spread
of S. aureus and especially MRSA has to take these bidirectional transmissions between animals and
humans into account [25,26].
The ability of S. aureus to colonize various host species is favored by its plastic genome, which
encompasses the core genome (75%), the core variable genome (10%) and the accessory genome (15%).
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The core variable genome contains the information for surface proteins and transcription regulators,
while the accessory genome consists mainly of mobile genetic elements (MGEs), and thus represents
the most variable part of the genome [27–29]. Unsurprisingly, the accessory genome plays a major
role in adaptation processes of S. aureus [30], allowing it to adapt to changing environments, such as
different host species. Prominent examples include: (i) lack of antibiotic resistance genes and the highly
human-specific immune evasion gene cluster (IEC) in animal isolates; (ii) lack of superantigen genes in
murine S. aureus isolates; (iii) acquisition of variants of the von Willebrand factor-binding protein in
ruminant and equine strains, carried by highly mobile pathogenicity islands (SaPIs); as well as (iv) a
single nucleotide mutation in the dltB gene, a gene involved in lipoteichoic acid biosynthesis, which
enabled a human strain to infect rabbits [10,11,31–34].
These host adaptation processes frequently restrict the host range that can be successfully colonized
and infected by a certain S. aureus lineage. In consequence, certain CCs seem to have a restricted
host spectrum, like ST5 in poultry or ST433 in pigs [35,36], while others, like CC8, CC22 and CC398,
display an extended host spectrum and are therefore called Extended-Host-Spectrum Genotypes
(EHSGs) [24,37,38].
Along with mice, rats are a common animal model for studying S. aureus pathogenicity and
new intervention strategies [39–41]. While investigating the epidemiology of S. aureus in both wild
and laboratory mice in previous studies, we have found distinct clonal lineages and hints for host
adaptation [11,34,42]. Moreover, certain mouse- and vole-adapted S. aureus strains turned out to be
suitable tools to improve murine infection models by allowing persistent intranasal colonization or
strongly reducing the required inoculation dose in infection models [42,43]. Despite their importance in
infection models, the prevalence of S. aureus in laboratory rats, and its mechanisms of host adaptation,
has yet to be investigated.
The major aim of this study was to extend our knowledge of S. aureus (esp. MRSA) carriage in
rats. This was achieved by collecting S. aureus strains from free-living and captive wild rats, as well as
laboratory rats, followed by determining the population structure and antibiotic resistance profiles of
these S. aureus isolates. Moreover, we looked for signs of host adaptation by screening for bacterial
genes known to be involved in this process.
2. Results
2.1. Laboratory Rats and Wild Rats Are Colonized with S. aureus
This study aimed at determining the prevalence and molecular epidemiology of S. aureus, including
MRSA, in free-living and captive wild rats, as well as laboratory rats. Therefore, 145 free-living wild
rats captured between 2009 and 2017 in three German federal states as well as in the Czech Republic
were analyzed for S. aureus nasal carriage (Tables S1 and S2). In addition, a total of 188 captive wild
rats originating from three German federal states and held in laboratory housing or large enclosures
for several years were investigated for S. aureus nasal carriage (Tables S3 and S4). Furthermore,
114 laboratory rats, raised as experimental or feeder animals, from four German federal states were
included (Tables S3 and S5). Finally, S. aureus isolates from 52 laboratory rats held in Germany, USA,
Japan and Canada were analyzed (Table S5).
Overall, the S. aureus carriage rate was similar among free-living wild rats (37/145; 25.5%) and
captive wild rats (41/188; 21.8%), but lower among laboratory rats (14/114; 12.3%) (Table 1). However,
within the different categories, the prevalence differed strongly according to the geographical location.
In free-living wild rats, the highest prevalence was seen in the Moravian-Silesian Region (MSR,
62.1%), followed by the German states Mecklenburg-Western Pomerania (MV, 22.2%), and then North
Rhine-Westphalia (NRW, 17.3%) (Table 1 and Table S6). The lowest prevalence was observed in pest
animals from a zoo in Baden-Württemberg (BW, 5.9%). This divergence was even more pronounced
among captive wild rats, where breeding procedures and hygiene measures can promote or prevent
the spread of S. aureus, respectively. For instance, S. aureus prevalence was very high (77.1%) in captive
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wild rats in Berlin (BE) (Table 1, Tables S4 and S7). In contrast, one wild rat population caught at a farm
and afterwards held in husbandry in NRW was completely S. aureus-free. Moreover, we observed
S. aureus-positive (e.g., Neufels, Tilbury) and -negative (e.g., BSR, WPHR) rat strain populations in the
same husbandry in Brandenburg (BB) (Tables S4 and S7). This suggests that the transmission between
strains is effectively blocked by hygiene measures. Colonization rates among laboratory rats were also
diverse and ranged from 0.0% (BW, NRW) to 33.3% (MV).
Table 1. Prevalence of Staphylococcus aureus in free-living wild rats, captive wild rats and laboratory rats.
Category 1 Country State 2 No. (Rats) S. aureus + (%) MRSA (%) 3 PenR (%) 4
Free-living wild
GER BW 17 1 (5.9) 1 (5.9) 1 (100.0)
GER MV 18 4 (22.2) 0 (0.0) 1 (25.0)
GER NRW_1 49 4 (8.2) 1 (2.0) 3 (75.0)
NRW_2 32 10 (31.3) 0 (0.0) 9 (90.0)
CZE MSR 29 18 (62.1) 0 (0.0) 1 (5.6)
Total 145 37 (25.5) 2 (1.4) 15 (40.5)
Captivewild
GER BB 72 14 (19.4) 5 (6.9) 5 (35.7)
GER BE 35 27 (77.1) 1 (2.9) 25 (92.6)
GER NRW 81 0 (0.0) 0 (0.0) 0 (0.0)
Total 188 41 (21.8) 6 (3.2) 30 (73.2)
Laboratory
GER BW 20 0 (0.0) 0 (0.0) 0 (0.0)
GER HE 40 7 (17.5) 0 (0.0) 5 (71.4)
GER MV 21 7 (33.3) 0 (0.0) 7 (100.0)
GER NRW 33 0 (0.0) 0 (0.0) 0 (0.0)
Total 114 14 (12.3) 0 (0.0) 12 (85.7)
1 Free-living wild rats: rats that were collected in the wild between 2009 and 2017 using live, electric as well as snap
traps, in addition to bait poisons; captive wild rats: offspring of wild rats that were bred in a laboratory setting or a
large enclosure for several years or even decades; laboratory rats: domesticated rats raised for animal experiments or
as feeder animals. 2 For captive wild rats, the state where the animal husbandry is located is provided. 3 % relative
to the total number of rats tested. 4 Determined based on the MIC of penicillin against S. aureus strains using the
broth microdilution method; resistance breakpoint was set to ≥ 0.25 µg/mL. Abbreviations: BB, Brandenburg; BE,
Berlin; BW, Baden-Württemberg; CZE, Czech Republic; GER, Germany; HE, Hesse; MIC, minimum inhibitory
concentration; MRSA, methicillin-resistant S. aureus; MSR, Moravian-Silesian Region; MV, Mecklenburg-Western
Pomerania; No., number; NRW, North Rhine-Westphalia (NRW_1; NRW_2, please refer to supplementary Table S2);
PenR, penicillin resistance; %, percentage; +, positive.
2.2. Wild Rats, Rats with Contact with Livestock and Laboratory Rats Carry Different S. aureus Clonal Complexes
The S. aureus population structure in our described rat cohorts was resolved by spa typing.
Free-living wild rats were predominantly colonized with two S. aureus lineages: CC130 (N = 21) and
CC49 (N = 15) (Figure 1A and Table S6). In addition, a single CC30 isolate was detected in a free-living
wild rat caught in a German town.
Interestingly, captive wild rats held in laboratories or large enclosures for several years were
colonized either with the above described rat-related lineages CC130 (N = 7) and CC49 (N = 1), the
wild mouse-related lineage ST890 (N = 5) or with the livestock-associated lineage CC398 (N = 28)
(Figure 1A and Table S7) [11]. For instance, wild rats whose predecessors were captured on a pig
farm in 2015 (strain Neufels) and kept under laboratory settings in two separate husbandries (BB and
BE) were mostly (28/41; 68.3%) colonized with CC398 (spa type t011) (Tables S4 and S7). However,
while the BB rats were colonized with CC398-MRSA (mecA-positive; see below), the BE rats carried
CC398-MSSA. These data imply that contact with livestock is a significant risk factor for the acquisition
of LA-S. aureus isolates. In contrast, the offspring of wild rats captured in a city were colonized with
CC130-MSSA and ST890-MSSA. S. aureus lineages commonly found in humans were not detected in
these animals.
On the other hand, laboratory rats raised as experimental animals or feeder animals harbored a
broad range of lineages (Figure 1A and Table S8). The most frequently detected lineage was CC15
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(N = 15), followed by CC8 (N = 10), CC88 (N = 9), CC7 (N = 6), CC1 (N = 5), CC5 (N = 5), and
CC188 (N = 5). Many of those are common in the human population, e.g., CC1, CC5, CC7, CC8, CC15,
and CC20 [44]. In addition, we detected a novel multilocus sequence type (MLST) in this cohort in
a laboratory rat from BW (MLST5598; spa type t2091). Notably, there was no overlap between the
S. aureus populations in laboratory rats and wild rats (both free living and captive).
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Figure 1. Wild rats and laboratory rats differ in their colonizing S. aureus population and the prevalence
of penicillin-resistant S. aureus. S. aureus isolates were obtained from free-living as well as captive
wild rats, in addition to laboratory rats. For a definition of the different rat categories, please refer to
the legend of Table 1. In addition, 52 S. aureus strains isolated from laboratory rats from Germany,
USA, Japan and Canada and characterized in this study were included in the analysis. The S. aureus
population structure was resolved by spa typing; related spa types were grouped into CCs. (A) Isolates
were clustered according to their origin (free-living wild rats, captive wild rats, laboratory rats). S. aureus
isolates from free-living wild rats with direct contact with livestock or from captive wild rats whose
ancestors have had contact with livestock are depicted in a lighter shade. (B) Prevalence of penicillin
resistance in the different lineages. Minimum inhibitory concentration (MIC) values for penicillin were
determined with the broth microdilution method.
To determine whether there are differences in the geographical distribution of the S. aureus lineages,
all determined lineages were assigned to a map. For captive wild rats, the location of the husbandry,
rather than their capture location, is depicted. Among wild rats (both free-living and captive), CC130
was most widely spread (Figure 2A). This lineage was detected in several rats from five German federal
states (BB, BE, BW, MV, and NRW), as well as in the Czech Republic (Moravian-Silesian Region, MSR).
Similarly, CC49 was detected in both free-living and captive wild rats originating from BE, NRW and
the Czech Republic (MSR).
Among the laboratory rats, CC8, CC15 and CC188 were most widely spread, with CC8 being
detected in rats from three continents (Figure 2A,B). CC1, CC7, and CC88 were observed in two
locations, while the remaining lineages were detected only at a single location. The validity of these
data is, however, restricted by the limited sampling size in some geographical locations (Table 1).
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Figure 2. The S. aureus lineages CC49 and CC130 are widespread among wild rats, whereas CC8, CC15
and CC188 are widespread among laboratory rats. The graph illustrates the occurrence of S. aureus
lineages (CC) in different federal states of Germany and the Czech Republic (A), as well as in Japan,
Canada and the USA (B). For a definition of the different rat categories, please refer to the legend
of Table 1. For captive wild rats, the location of the husbandry, rather than their capture location, is
depicted. The different lineages are color coded; S. aureus isolates from free-living and captive wild rats
are depicted in differentially-striped bars. S. aureus isolates from laboratory rats are shown in solid
bars. The absolute number of isolates is depicted on top of the bars. Abbreviations: BB, Brandenburg;
BE, Berlin; B , Baden-Württemberg; HE, Hesse; MV, Mecklenburg-Western Pomerania; NRW, North
Rhine-Westphalia; MSR, Moravian-Silesian Region.
2.3. Penicillin Resistance Was Low in Wild Rats but High in Rats with Livestock Contact
We have previously reported that murine S. aureus isolates show a lower prevalence of penicillin
resistance than human strains [34]. To extend these findings, we determined the MIC of penicillin for
all rat-derived S. aureus isolates using the broth microdilution method. Overall, 95/144 (66.0%) isolates
were penicillin-resistant, however the prevalence varied significantly between the groups (Chi-Squared
test, p < 0.001). While the resistance rate was low in S. aureus isolates from free-living wild rats (15/37;
40.5%), it averaged 73.2% (30/41) in captive wild rats and 75.8% (50/66) in laboratory rats. The highest
rate of penicillin resistance (96.3%; 26/27) was observed in rats with livestock contact (Table 1, Tables
S6 and S7). This pattern is also reflected by varying rates of penicillin resistance in S. ureus lineages
associated with either free-living wild rats (CC49, CC130), captive wild rats (CC130, ST890), laboratory
rats (various CCs) and captive wild rats with previous livestock contact (CC398) (Figure 1A,B).
2.4. MRSA Was Detected among Wild Rats, but Not among Laboratory Rats
In general, several wild rats were colon z d with MRSA, while the laboratory rat population
was free of MRSA (Table 2). In total, 6/188 (3.2%) captive wild r t and 2/145 (1.4%) free-living wild
rats were colonized with MRSA. Five out of six MRSA-positive captive wild rats ere colonized with
CC398-MRSA. Interestingly, all affected rats were derived from the same rat strain (Neufels) in BB
within the same year. These animals originated from black rats (Rattus rattus) caught at a livestock
farm in Southern Germany and have been bred in BB since 2015. All five strains belonged to the same
spa-type (t011), carried the methicillin-resistance gene mecA and showed an identical resistance pattern,
suggesting the maintenance and spread of a single MRSA clone during captive breeding (Table 2).
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Table 2. MRSA isolates from free-living and captive wild rats.
Category 1 Strain ID Habitat 2 Country 3 State 3 Strain Species Year
spa
Type CC
mec
Genes 4
MRSA
agar Cef
R Oxa-MIC
(µg/mL) Interpretation
Free-living wild KS/17/175 town GER NRW_1 NA Rattus norvegicus 2016 t685 CC30 mecA + + Oxa ≤ 0.25 MRSA 5
KS/17/378 zoo, pest animal GER BW NA R. norvegicus 2012 t843 CC130 mecC + + Oxa ≤ 0.25 MRSA 5
Captive wild
KS/17/19 livestock farm GER BB Neufels R. rattus 2016 t011 CC398 mecA + + Oxa ≥ 4 MRSA
KS/17/20 livestock farm GER BB Neufels R. rattus 2016 t011 CC398 mecA + + Oxa ≥ 4 MRSA
KS/17/21 livestock farm GER BB Neufels R. rattus 2016 t011 CC398 mecA + + Oxa ≥ 4 MRSA
KS/17/22 livestock farm GER BB Neufels R. rattus 2016 t011 CC398 mecA + + Oxa ≥ 4 MRSA
KS/17/46 livestock farm GER BB Neufels R. rattus 2016 t011 CC398 mecA + + Oxa ≥ 4 MRSA
KS/17/390 livestock farm GER BE Neufels R. rattus 2017 t843 CC130 mecC + + Oxa ≤ 0.25 MRSA5
1 For a definition of the different rat categories, please refer to the legend of Table 1. 2 For captive wild rats, the habitat of the captured ancestral rats is reported. 3 For captive wild rats,
the location of the husbandry rather than the capture location is reported. 4 PCR for mecA, mecB, mecC and mecD. 5 Probably heterogenous expression of the PBP2a protein. Abbreviations:
BB, Brandenburg; BE, Berlin; BW, Baden-Württemberg; CC, clonal complex; CefR, cefoxitin resistance; GER, Germany; mec, methicillin resistance coding gene; MRSA, methicillin-resistant
S. aureus; NA, not applicable; NRW, North Rhine-Westphalia; Oxa-MIC, oxacillin minimum inhibitory concentration.
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Moreover, we detected two mecC-encoding CC130 isolates (spa type t843) in wild rats. One of the
rats was caught in a zoo as pest rodent, while the other was a captive wild rat. In addition, a Norway
rat positive for CC30-MRSA encoding the mecA gene was caught in a city. All three isolates were
phenotypically resistant to cefoxitin, but sensitive to oxacillin, suggesting a heterogenous expression of
the PBP2a protein. mecB- and mecD-positive S. aureus isolates were not detected in this study.
2.5. S. aureus Isolates from Rats Show Features of Host Adaptation
We have previously reported that murine S. aureus isolates from laboratory and wild mice and
voles have adapted to their rodent host by eliminating human-specific phage-carried immune evasion
(IEC) genes as well as MGE-carried SAg genes [11,34,45]. To test whether S. aureus isolates from rats
show similar features of host adaptation, we compared the presence of IEC genes and the SAg gene
repertoire with CC-matched human isolates.
Sa3int phages harbor the human-specific IEC encoding staphylokinase (SAK), staphylococcal
complement inhibitor (SCIN), chemotaxis inhibitory protein of S. aureus (CHIPS) as well as
staphylococcal enterotoxins A or P (SEA, SEP) [46,47]. IEC-encoding prophages are prevalent
in human S. aureus isolates, but frequently absent in animal-adapted strains, including murine and
vole S. aureus isolates [11,34,44]. In line with this, only 1/37 (2.7%) isolates from free-living wild rats,
none of the S. aureus isolates from captive wild rats (0/41) and 39/66 (59.1%) of laboratory rats harbored
the phage-carried IEC genes sak, chp and/or scn (Tables S6–S8). A CC-wise comparison of the most
prevalent rat S. aureus lineages with matched human strains revealed that IEC genes were significantly
less frequent or even absent in the rat-derived CC8, CC49, CC88, and CC398 isolates (Table 3).
Table 3. Prevalence of phage-carried IEC genes and MGE-carried SAg genes in rat and matched human
isolates 1.
Rat Human
No. Total % No. Total % p Value 2
Phage-carried IEC genes
CC7 6 6 100.0 10 10 100.0 n.s.
CC8 0 10 0.0 9 10 90.0 p < 0.001
CC49 0 14 0.0 3 4 75.0 p < 0.001
CC88 3 9 33.3 10 10 100.0 p < 0.01
CC130 0 28 0.0 0 9 0.0 n.s.
CC398 0 15 0.0 5 7 71.4 p < 0.001
MGE-carried SAg genes
CC7 3 6 50.0 9 10 90.0 n.s.
CC8 0 10 0.0 7 10 70.0 p < 0.01
CC49 0 14 0.0 0 4 0.0 n.s.
CC88 0 9 0.0 5 10 50.0 p < 0.05
CC130 0 28 0.0 0 9 0.0 n.s.
CC398 0 15 0.0 0 7 0.0 n.s.
1 Only CCs with N ≥ 5 were considered. To avoid a bias due to highly prevalent clones, a maximum number of
five genotypically identical isolates from the same area and year were included. 2 Chi-squared test. Abbreviations:
IEC, immune evasion cluster; MGE, mobile genetic elements; No., number; n.s., non-significant; SAg, superantigen;
%, percentage.
SAg genes are prevalent in human S. aureus isolates (ca. 80%, not considering selX in the core
genome) [44]. In contrast, only 1/37 (2.7%) isolates from free-living wild rats, none of the S. aureus
isolates from captive wild rats (0/41) and 21/66 (31.8%) isolates of laboratory rats harbored SAg genes.
In 12 of these 22 strains, these SAg genes were located on MGEs (Tables S6–S8). A CC-matched analysis
revealed that MGE-carried SAg genes were significantly less frequent in rat CC8 and CC88 isolates
than their human counterparts (Table 3). For instance, seven out of 10 human CC8 isolates harbored
the plasmid-carried staphylococcal enterotoxin genes sed/sej/ser, the phage-carried sea/sep, and/or the
SaPI-carried seb/sek/seq (Table 3 and Table S9). In contrast, all ten rat CC8 isolates lacked SAg genes
(Table S8). Similarly, 50% of human CC88 isolates were positive for SAg genes, while all nine rat CC88
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isolates were negative (Tables S8 and S9). Taken together, S. aureus isolates from laboratory rats and
wild rats rarely harbor phage-carried IEC genes and MGE-carried SAg genes, suggesting long-term
adaptation to their hosts.
2.6. Both CC and Origin of S. aureus Determine Its Coagulation Behavior
The coagulation of the host’s plasma is a typical virulence trait of host-adapted S. aureus strains [31].
None of the tested strains was able to completely coagulate plasma obtained from Sprague Dawley
rats (Figure 3). Nevertheless, the formation of small to large clots was observed, and after 24 h of
incubation, human CC88 strains formed the biggest clots. Looking at the kinetics of coagulation, rat
CC49 strains coagulated rat plasma faster than all other tested strains whose coagulation behavior
was similar within the first 5 h. Moreover, the rat CC49 strains were the only ones able to reduce the
coagulation score, i.e., disintegrate the already formed clots, over time.
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3. Discussion
While wild rats are a known reservoir for MRSA, the natural S. aureus population in wild and
laboratory rats has not been described in detail [18,19,21]. Here, we determined the prevalence of
S. aureus including MRSA in free-living and captive wild rats, as well as laboratory rats (Table 1).
We observed striking differences between these three major cohorts. Free-living wild rats as well as
those captured and held in husbandry were mainly colonized with the S. aureus lineages CC49 and
CC130. In contrast, laboratory rats were colonized with various lineages, mostly of human origin
(Figure 1). Rats with contact with livestock were frequently colonized with the livestock-associated
lineage CC398; some of the isolates were even methicillin-resistant (Figure 1, Table 2). S. aureus isolates
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from rats showed features of host adaptation on both the genetic as well as the phenotypic level
(Table 3). These results underline the importance of rats as reservoir for MSSA as well as MRSA.
3.1. Wild Rats Are Predominantly Colonized with The S. aureus Lineages CC49 and CC130
One-quarter (25.5%) of the examined wild rats were positive for S. aureus. These S. aureus-positive
rats were detected in different areas of Germany and the Czech Republic over a time period of eight
years, suggesting that S. aureus colonization of rats is widely distributed. Hence, rats can be considered
as a natural host of S. aureus. Compared to other species, e.g., humans, the diversity of the detected
lineages is quite low, although this might be affected by the small sample size in some cohorts [44].
Interestingly, the two dominating lineages, CC130 and CC49, could also be found in wild mice and
voles, as we have reported previously [11]. The lineage CC130 has already been isolated from a
Norway rat [10] and shows a broad host spectrum, especially in wildlife. It has been detected in red
foxes, hedgehogs, brown hares, wild boar, rabbits and magpies all over Europe and Tunisia [10,48–50].
In contrast to our study, most of the previously described CC130 isolates were MRSA, harboring the
mecC locus.
CC49 strains show a less diverse host spectrum and have mostly been isolated from wild animals
such as bank voles, squirrels and wild boar in Central Europe and Spain [10,11,51–53]. Usually, these
isolates show an MSSA phenotype, but MRSA (both mecA and mecC positive) were also found in pigs,
horses, and humans [54–56]. This suggests that SCCmec elements are predominantly acquired and
maintained in environments with significant selective pressure due to the use of antibiotics [57,58].
3.2. Rats with Contact with Livestock Frequently Carry CC398
Captive wild rats whose predecessors were captured on a pig farm in 2015 (strain Neufels) and
kept under laboratory settings in two separate husbandries (BB and BE) were mostly (90.3%) colonized
with CC398-MSSA (Tables S4 and S7). However, while the BB rats were colonized with CC398-MRSA
(mecA-positive), the BE rats carried CC398-MSSA. CC398-MRSA have been repeatedly reported from
rats trapped on farms and even within inner city centres [18,19,21]. Since two of these studies focused
only on MRSA, epidemiological data on CC398-MSSA are rather scarce.
CC398-MRSA are highly prevalent in German livestock, but CC398-MSSA have also been
reported [59,60]. Thus, it can be assumed that the CC398 strains were acquired from livestock and
spread within the rat population, as this type of acquisition and spread has already been described for
other lineages and host species [30,35,61]. There are several possible scenarios: First, CC398-MRSA
could have been transmitted from livestock to rats and subsequently lost the SCCmec element in
BE husbandry. Second, CC398-MSSA could have been transferred from pigs to rats and the BB
subpopulation subsequently acquired the SCCmec element. Third, both CC398-MSSA and -MRSA
could have been transmitted to rats with the former being maintained in the BE and the latter in the
BB rat population. The detection of a LA-S. aureus lineage in captive wild rat populations years to
decades after acquisition of the ancestral animals suggests a stable colonization of rats and an effective
transmission to their offspring, similar to what has been observed in laboratory mice [45]. Since CC398
belongs to the EHSG, it is still unclear whether this effective acquisition of LA-S. aureus strains holds
true for all S. aureus lineages or just to certain ones. Nevertheless, we can conclude that wild rats can
act as reservoir for LA-S. aureus, including LA-MRSA, making the containment of those pathogens
even more challenging than previously assumed.
3.3. Laboratory Rats Carry Various Lineages, Mostly of Human Origin
Laboratory rats carried a high diversity of S. aureus lineages—many of which are commonly found
in humans, e.g., CC1, CC5, CC8, CC15 and CC101 [44]. Considering the close contact of laboratory rats
with humans over many decades, it is only reasonable to assume that these strains have originally
been transmitted from humans to rats. This might be supported by the fact that there is a significant
overlap with the S. aureus population in laboratory mice [34], implying that humans could be the
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prime source of new S. aureus strains in laboratory animals. Transmission of S. aureus from humans to
animals has been described several times [62]. However, it seems likely that not all human-adapted
lineages are able to colonize rats. For instance, the most common human lineages (CC30 and CC45) are
almost completely absent in the rat population and have also only rarely been detected in laboratory
mice [34,44].
On the other hand, colonizing lineages such as CC88 and CC188 have already been described in
other rodents and are rarely found in humans, suggesting that they might represent rodent-specific
lineages [11,34]. Their origin, however, remains unclear. They might have originated from the human
population and introduced into the rat colony by animal caretakers, with subsequent adaptation to
their new rodent host over time. Alternatively, they might have already been present in the ancestry
rat population at the time when commercialized breeding was established. Nevertheless, the low
prevalence of phage-carried IEC genes and MGE-carried SAg genes in all rat-derived S. aureus lineages
suggests a long-term colonization of these hosts.
3.4. Captive Wild Rats Maintain Their S. aureus Population
Three of the analyzed rat husbandries (located in the German federal states BB, BE, and NRW)
harbored wild rats that have been maintained in captivity for several years. Two of these husbandries
were S. aureus-positive (19.4% in BB, 77.1% in BE), while in the NRW cohort, S. aureus was completely
absent. Within the same husbandry in BB both S. aureus-positive (e.g., Neufels, Tilbury) and -negative
(e.g., BSR, WPHR) rat strains were detected (Table S4). This suggests that a transmission between
different rat strains was effectively prevented by the implemented hygiene measures. This finding is
supported by similar observations in laboratory mice [45].
In addition, the captive wild rats are of interest, because they allow some conclusions about the
stability of the S. aureus population after adaptation to a new environment with no further contact
with wildlife, but increased contact with humans. The S. aureus-positive cohorts of captive wild rats
(located in BB, and BE) were still colonized with S. aureus lineages common in wild rats (CC49, CC130)
and livestock (CC398), while typical human S. aureus lineages, which were common in laboratory
rats (see above), were not detected, even though they included animals crossed with laboratory rats
(Table S5). This may be explained by a high stability of the S. aureus population in the rat cohort [63].
The absence of typical human S. aureus lineages suggests that several factors, including the existing
microbiome [64–66], the limited contact of caretakers to animals, as well as high hygienic standards
(including wearing coats and gloves) successfully prevent the introduction of human-adapted S. aureus
strains. Moreover, the rat-adapted S. aureus population may be able to outcompete introduced
human-adapted S. aureus strains. Indeed, we have previously observed that the S. aureus population in
laboratory mice is stable over years, and that these bacteria are very effectively transmitted to their
offspring [45]. Whether this holds true for rats as well needs to be further investigated.
3.5. S. aureus Isolates from Rats Likely Adapt to Their Host by Eliminating MGEs Carrying Human-Specific
Virulence Factors
A comparison of rat and CC-matched human S. aureus isolates showed that the rat strains are
probably adapted to their host on both genetic and phenotypic levels. The observed scarcity of the
phage-carried IEC genes, especially among S. aureus isolates from wild rats, indicates a strong selection
against these genetic elements. Several phage-encoded immune evasion factors show no or little activity
on rat cells [67–70]. For example, both CHIPS and SCIN efficiently block complement activation in
humans but show no activity in mice and rats [67,70]. In contrast, SAK shows thrombolytic activity also
in rats [71]. In addition, the Sa3int phage integrates into and thereby inactivates a known staphylococcal
virulence gene, the sphingomyelinase hemolysin beta (hlb) gene. Hlb lyses erythrocytes, lymphocytes
and keratinocytes and contributes to skin colonization in mouse models [72]. Thus, eliminating the
Sa3int phage and thereby restoring the hlb gene could be advantageous for colonizing rats. In line with
this, we have previously observed that this prophage is rare in S. aureus populations from laboratory
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and wild mice [11,34,45]. Indeed, the lack of the phage-carried IEC genes is a well-known marker for
S. aureus isolates of animal origin [46,73,74].
Another genetic correlate of host adaptation was the absence of MGE-carried SAg genes in the
lineages CC8 and CC88. This confirms previous observations in wild and laboratory mice, where
S. aureus isolates also lacked MGE-carried SAg genes. S. aureus SAgs activate human T cells in the
picomolar concentration range in vitro but show a 100–1000-fold reduced activity on rat T cells and a
10–100-fold reduced activity on murine T cells [69,75,76]. Elimination of SAg genes in S. aureus isolates
from rats, whenever their genetic location permits this, underlines their expendability in rats.
3.6. Rat-derived CC49 Isolates Show Enhanced Procoagulatory Activity on Rat Plasma
Blood coagulation is a major virulence trait of S. aureus, and some pro- or anticoagulatory factors
are known to be host specific [31]. Therefore, we compared the pro-coagulatory activity of CC49 and
CC88 isolates from rats with their matched human counterparts. Rat CC49 isolates coagulated rat
plasma faster than matched human CC49 isolates. In contrast, we observed no difference in our test
system for the CC88 isolates. In line with our data, Viana et al. reported that ruminant-derived strains,
but not human isolates, had the capacity to stimulate clotting of ruminant plasma due to a unique
MGE-encoded paralogue of the von Willebrand factor binding protein [33]. The molecular basis for the
observed differences in our rat-derived S. aureus isolates will be clarified by whole-genome sequencing
in future studies.
3.7. Rats Carrying Human-Derived or LA-MRSA Present a Human Health Risk
Considering the growing public health relevance of LA-MRSA, i.e., CC398-MRSA, in human health
and livestock farming [13,77,78], there is an urgent need to elucidate potential transmission routes.
S. aureus/MRSA is not only transmitted via person-to-person contact, but can also spread among and
between domestic animals, livestock and people via direct contact or inhalation of contaminated air and
dust in stables [79,80]. Moreover, pest species, including rats, are a potential source of MRSA [18,19,21].
Taking the “One Health” concept into consideration, measures to control the spread of S. aureus, and in
particular MRSA, must take these different reservoirs and transmission routes into account.
Rats actively explore a number of different habitats, and therefore have a unique opportunity to
encounter a variety of human and livestock pathogens [16,81–83]. Indeed, there is growing evidence
that rats play a role in the spread and persistence of MRSA on pig farms [18,21]. Their ability to cover
considerable distances allows rats to spread pathogens from one herd to another [84,85]. Besides farm
animals, rats might also transfer livestock-derived S. aureus from farms to domestic animals or pets,
and ultimately to humans through contact with these animals or their excrements. In addition, they
might also serve as a ‘mixing vessel’, facilitating the transfer of genetic elements encoding resistance
genes either between different S. aureus strains or between S. aureus and other bacterial species [19].
Thus, strategies to control MRSA on farms should take pest control into account.
Rats are not only a reservoir for LA-MRSA but also HA-MRSA. In our study, we observed
a single CC30-MRSA-positive rat caught within a city. Similarly, Himsworth et al. reported an
MRSA-colonization rate of 3.5% among tested urban rats, mostly involving human MRSA common
in that area, such as USA300, but also CC398-MRSA [19]. While the risk of rat-to-human MRSA
transmission outside the farm setting is very low, it could become relevant in impoverished, inner-city
neighborhoods, where socio-economic factors might promote rat infestations and hence rat-to-human
contact [19,81,86]. Moreover, the occupational risk of encountering MRSA-colonized rats is quite
considerable in case of sewage workers or workers on landfill sites.
In addition to the known infection risk due to colonized free-living wild rats, we report here that
captive wild rats may also be a source of MRSA. To avoid transmission and subsequent infection of
caretakers, strict hygiene measures, including the use of gloves and face masks, as well as proper
disinfection of cages should be implemented.
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The observed elimination of human-specific virulence genes, i.e., IEC-carried immune evasion
genes as well as SAg genes, in rat-derived S. aureus isolates raises the question, whether they are
capable of colonizing and infecting humans. We propose that the potential to colonize and/or infect
humans depends on a lineage-specific repertoire of host-specific or broadly-reactive adhesins, immune
evasion as well as virulence factors. On the one hand, human colonization and infection with CC49
has only rarely been reported [44,56,87], suggesting a reduced fitness and virulence of these strains
in humans. In line with this, caretakers in animal breeding facilities were not colonized with the
endogenous rat- or mouse-adapted S. aureus strains (personal communication, S. Holtfreter) [45].
On the other hand, zoonotic CC398-MRSA are commonly encountered among farm workers or
other individuals with professional contact with livestock, thus promoting the spread of CC398-MRSA
in the general population and introducing this lineage in hospitals and other healthcare facilities.
A recent study demonstrated that these strains are able to cause all types of infections attributed to
S. aureus; nevertheless, the disease-burden of LA-MRSA seems to be lower compared to other MRSA
lineages [78]. The factors driving the spread of this zoonotic lineage in the human population are not
understood yet. Interestingly, the livestock-associated CC398 originated from a human CC398-MSSA.
Upon host switch, it eliminated the IEC-carrying Sa3int phages and acquired methicillin resistance [88].
Conversely, one could assume that a re-acquisition of these phages promotes the spread of zoonotic
CC398-MRSA in the human population. However, a recent study demonstrated that the acquisition of
IEC-encoding Sa3int phages is no major driver for the re-adaptation of CC398-MRSA to the human
host [89].
4. Conclusions
S. aureus, particularly MRSA, has a major impact not only on human health, but also on farm and
companion animals as well as wildlife. Rats are key players in the ecology of MRSA on farms and may
also transmit human MRSA. Overall, our data show that rats harbor a natural S. aureus population,
consisting mainly of CC49- and CC130-MSSA. However, contact with humans or livestock poses a
colonization pressure on rats, reflected in the uptake and long-term carriage of S. aureus isolates of
human or livestock origin. Laboratory rats represent a special case, because they lack the lineages CC49
and CC130 and instead carry lineages that are likely human-derived. Upon transfer to rats, S. aureus
strains seem to adapt to their new host by removing futile genetic elements carrying human-specific
immune evasion genes or SAg genes. Future studies should further investigate S. aureus ecology in
different settings, e.g., farms versus inner-city environments, as well as among different rat species,
i.e. Rattus rattus versus Rattus norvegicus, and should consider sampling all possible hosts including
wild animals (particularly rats), livestock, pets and humans as well as the abiotic environment (e.g., dust
samples), to gain a better understanding of transmission and maintenance dynamics. In light of
the “One Health” concept, such investigational studies could provide the conceptual foundation for
developing effective measures to contain these dangerous pathogens in the future.
5. Materials and Methods
5.1. Study Design and Ethics Statements
The subjects of the study were 447 rats (Rattus norvegicus, N = 381; Rattus rattus, N = 66), mostly
from Germany (N = 418), but also from Czech Republic (N = 29), which were either free-living wild
rats (N = 145), captive wild rats (N = 188) or laboratory rats (N = 114).
The category “free-living wild rats” comprises rats that were collected in the wild between 2009
and 2017 using live, electric as well as snap traps, in addition to bait poisons, at different locations in
Mecklenburg-Western Pomerania (N = 18), North Rhine-Westphalia (N = 81), and Baden-Württemberg
(N = 17) [90] as well as in the Moravian-Silesian Region in the Czech Republic (N = 29) (Figure 1).
Details on the geographical origin, habitat, and capture method of these free-living wild rats as well as
on their characteristics and nasal S. aureus colonization are described in Tables S1 and S2, respectively.
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The category “captive wild rats” comprises offspring of wild rats that were bred in a laboratory
setting or a large enclosure for several years or even decades. Details on the geographical origin,
source, original habitat, housing conditions and hygiene measures in these animal facilities, as well as
on the rat characteristics and nasal S. aureus colonization are described in Tables S3 and S4, respectively.
The category “laboratory rats” comprises domesticated rats raised for animal experiments or as feeder
animals (Tables S3 and S5).
Samples were collected using approved methods, according to relevant legislation and by
permission of the responsible State authorities whenever necessary (Supplementary Tables S1 and S3).
Wild rats were captured by professional pest control operators, and hence no capture permit was
required. The only exception were wild rats from NRW (NRW_2; Supplementary Table S1), which
were captured using live traps following approval by the North Rhine-Westphalia State Agency for
Nature, Environment and Consumer Protection, No. 84-02.04.2015.A279 (03.11.2015).
Captive wild rats were held in animal facilities in BB, BE, and NRW based on holding permits
provided by the responsible Veterinary or State Office at the indicated date (BB: Veterinary Office
of the district of Potsdam-Mittelmark (23.06.2014); BE: State Office for Health and Social Issues, No.
IC 114 -ZH25 (10.04.2014); NRW: Health and Veterinary Office Münster, No. #39.32.7.1 (09.12.2013).
An additional animal ethics permit was granted for animals in NRW by the North Rhine-Westphalia
State Agency for Nature, Environment and Consumer Protection, No. 84-02.04.2013.A288 (29.11.2013).
Laboratory rats were held as feeder animals under a general zoo permit in locations in BW (No.
DE 08 111 100115; 12.08.2011) and HE (Darmstadt Regional Council, No. V 51.1 – 1.1 – R 25.3 – ZRL –
Kronberg, Opel-Zoo; 19.04.2016). Moreover, laboratory rats were held in laboratory settings under a
holding permit from the local authorities in MV (Veterinary and Food Inspection Office, district of
Vorpommern-Greifswald, No. Dr.Caa.ZSF3936/11/17; 07.11.2017) and NRW (Health and Veterinary
Office Münster, No. #39.32.7.1; 09.12.2013). An additional animal ethics permit was granted for
animals in NRW by the North Rhine-Westphalia State Agency for Nature, Environment and Consumer
Protection, No. 84-02.04.2013.A288 (29.11.2013).
Dead animals were immediately frozen and stored at −20 ◦C until dissection. Their noses were
aseptically removed from the body and frozen again at −20 ◦C.
S. aureus isolates from laboratory rats: We also included S. aureus isolates in this study, which
were obtained from laboratory rats by collaborators. The CR strains (N = 38) were provided by
Charles River’s Research Animal Diagnostic Services (Wilmington, USA). Strains were submitted by
different Charles River facilities, as well as from Charles River customers (pharmaceutical companies,
universities, or research institutes). 13 S. aureus isolates were obtained during routine health monitoring
or from euthanized rats suffering from S. aureus infections (e.g., abscesses) at the animal facilities of
the German Cancer Research Center (DKFZ, Deutsches Krebsforschungszentrum, Heidelberg, BW,
Germany) in Heidelberg, Germany between 1983 and 2014. A single S. aureus isolate was obtained from
the caecum of R. norvegicus during routine health monitoring at the animal facilities of the University
of Ulm (Tierforschungszentrum, Ulm, BW, Germany).
S. aureus isolates from humans: Fifty CC-matched human S. aureus strains were derived from
several S. aureus colonization studies (T, SH, SHIP) [44,91,92]. The T and SH strains were obtained
from healthy blood donors in Northern Germany in 2002 and 2005–2006, respectively. Spa types as
well as agr type, SAg gene patterns and S. aureus integrase (Saint) phage groups of these strains were
previously reported [91,92]. The SHIP studies (SHIP-2, SHIP-Trend-0) are population-based studies in
Western Pomerania and are described in depth elsewhere [44,93]. Human CC49, CC88, and CC130
isolates were derived from strain collections of the Robert Koch-Institute and the Institute for Medical
Microbiology and Hygiene, Technical University of Dresden.
5.2. Sample Preparation and Screening for S. aureus
The rat noses were thawed at room temperature for 1 h and then transferred into tubes containing
1 mL BBL™ Phenol Red Mannitol Broth (MSB: 10 g/L pancreatic digest of casein; 75 g/L NaCl; 5 g/L
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D-mannitol; 18 mg/L phenol red in double-distilled water). The noses were homogenized using
2 rounds of spinning (6000/min, 2 × 20 s; 15 s breaks) in the presence of 1.4 and 2.8 mm Zirconium
oxide beads (Bertin Precellys 24 homogenizer, VWR, Darmstadt, Germany). Aliquots of 100 µL of the
homogenate were plated onto mannitol salt agar (MSA) plates (Becton, Dickinson and Co., Franklin
Lakes, NJ, USA) and incubated for 48 h at 37 ◦C. The rest of the homogenate was subsequently
transferred to a 50 mL tube and cultured aerobically in MSB (total volume 5 mL) for 48 h at 37 ◦C under
agitation for bacterial enrichment.
Three random samples from MSA plates containing golden-yellow colonies were used for a
mixed-colony PCR to detect S. aureus presence by testing for gyrase (gyr) and nuclease (nuc) genes.
In brief, bacterial cells were resuspended in reaction mix (25 µL) containing 1× GoTaq® Flexi buffer,
100 µM deoxynucleoside triphosphates (dATP, dCTP, dGTP, and dTTP; buffer and nucleotides from
Thermo Fisher Scientific Baltics UAB, Vilnius, Lithuania), 5 mM MgCl2, 320 nmol/L of each primer,
1.0 U GoTaq® G2 Flexi DNA polymerase (Promega, Mannheim, Germany) in DNase- and RNase-free
water. PCRs were performed as follows: an initial denaturation step at 95 ◦C for 10 min was followed
by either 30 cycles of amplification (16SrRNA, nuc: 95 ◦C for 30 s, 55 ◦C for 30 s and 72 ◦C for 60 s) or
35 cycles of amplification (gyr: 95 ◦C for 30 s, 60 ◦C for 30 s and 72 ◦C for 60 s), ending with a final
extension phase at 72 ◦C for 7 min. All PCR products were resolved by electrophoresis in 1.5% agarose
gels (1× TBE buffer), stained with RedSafe™ (INtRON Biotechnology, Sungnam, Korea) and visualized
under UV light (GenoPlex, VWR, Darmstadt, Germany).
A positive result indicating the presence of S. aureus was followed by subculturing 3 distinct
colony morphotypes on sheep blood agar (Becton, Dickinson and Co, Franklin Lakes, NJ, USA; 37 ◦C;
24 h). The colonies were further tested using the S. aureus-specific latex agglutination test (ProlexTM
Staph Xtra Latex Kit, Pro-Lab Diagnostics, Richmond Hill, ON, Canada). Finally, S. aureus isolates
were subjected to colony PCR (gyr, nuc). DNA isolation was performed on all PCR-positive S. aureus
isolates using the DNeasy Blood and Tissue Kit (Qiagen, Venlo, the Netherlands) according to the
manufacturer’s instructions, but with an addition of 0.1 mg/ mL lysostaphin (Sigma-Aldrich, St. Louis,
MI, USA) to the lysis buffer [11]. S. aureus isolates were stored as glycerol stocks.
5.3. S. aureus Identification
The colonies obtained were screened for S. aureus using an S. aureus-specific colony multiplex PCR.
The amplification of the 16SrRNA gene served as quality control (756 base pairs (bp); 16SrRNA_forward
primer 5′-AAC TCT GTT ATT AGG GAA GAA CA-3′, 16SrRNA_reverse primer 5′-CCA CCT TCC
TCC GGT TTG TCA CC-3′) [94], and the S. aureus-specific gyr gene (281 bp; Gyr_forward primer
5′-AGT ACA TCG TCG TAT ACT ATA TGG-3′, Gyr_reverse primer 5′-ATC ACG TAA CAG TTC AAG
TGT G-3′) as well as the S. aureus species specific nuc gene (279 bp; Nuc_forward primer 5′-GCG ATT
GAT GGT GAT ACG GTT-3′, Nuc_reverse primer 5′-AGC CAA GCC TTG ACG AAC TAA AGC-3′)
were used to detect S. aureus DNA [11,94].
5.4. Spa Genotyping and Multilocus Sequence Typing (MLST)
Based on the allelic profile of seven house-keeping genes, the species S. aureus can be divided
into STs, which again are grouped into CCs [95]. Spa typing and MLST were performed as described
elsewhere [96,97]. Spa typing was performed on all S. aureus isolates, and isolates were assigned to CCs
based on spa typing results [34]. MLST was performed on selected isolates to confirm the spa clustering
results. Profiles were submitted to the SpaServer and the MLST database (https://pubmlst.org/saureus/).
5.5. Virulence Gene Detection Using Multiplex PCR
More than 30 S. aureus genes, including gyr, methicillin resistance (mecA-mecD, mecU), agr group 1–4
genes, as well as the virulence genes for Panton-Valentine leukocidin (pvl), staphylococcal superantigens
(sea-see, seg-seu, tst), and exfoliative toxins (eta, etd) were examined as described elsewhere [92,98].
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S. aureus bacteriophage types (Sa1int-Sa7int) and the Sa3int phage-carried IEC genes (sa3int, sak, chp,
scn) were examined with multiplex PCR according to published protocols [44].
5.6. MIC of Penicillin against S. aureus Strains Using the Broth Microdilution Method
The MIC of penicillin G (Merck KGaA, Darmstadt, Germany) was determined in a total volume
of 0.1 mL of Mueller-Hinton broth (MHB: casein acid hydrolysate 17.5 g/L; Beef extract 3 g/L; Starch
1.5 g/L; Merck KGaA, Darmstadt, Germany) containing approximately 5 × 105 colony-forming units
(CFU)/mL in microdilution trays with round-bottom wells (CELLSTAR®, greiner bio-one) according
to the CLSI broth microdilution method [99]. The following control strains were included: S. aureus
ATCC® 43300 (MRSA) and S. aureus ATCC® 29213 (bla+) as positive controls; S. aureus ATCC® 25923
(bla-) as a negative control. In addition, medium sterility as well as growth controls were included in
the assay. The penicillin range tested was 0.001–16 µg/mL, whereas the resistance breakpoint was set
to ≥0.25 µg/mL according to CLSI guidelines [99]. The inoculated microdilution trays were sealed and
incubated at 37 ◦C for 24–48 h in an ambient air incubator. The MIC values were determined as the
lowest penicillin concentration that completely inhibits growth of the organism in the microdilution
wells as detected by the unaided eye.
5.7. Antibiograms and mecA-D PCR
The strains were grown on chromID® MRSA SMART Agar (BioMérieux, Nürtingen, Germany).
Susceptibility testing was performed by Vitek 2 AST applying AST-P654 card (BioMérieux). Methicillin
resistance was verified by Alere™ PBP2a SA Culture Colony Test (Abbott Rapid Diagnostics, Cologne,
Germany) and PCR tests addressing the different mec genes as described elsewhere for mecA, mecC and
mecD [100,101]. For mecB detection, the primer pair mecB-f (5′- GAT GTA CTG TTG CTT CTC TTA
A-3′) and mecB-r (5′-CAG AGG GAA AAT ACT AGA C-3′) was designed and tested using S. aureus
UKM4229 [102] as reference strain.
5.8. Coagulation Assay
Rat CC88 isolates (N = 5) and human CC88 isolates (N = 5), as well as rat CC49 isolates (N = 5)
and human CC49 isolates (N = 4) were grown for 7 h at 37 ◦C and 200 rpm in tryptic soy broth (TSB) to
reach the early stationary phase. The OD of the TSB cultures was adjusted to 4. Seventy microliters
of the adjusted bacterial cultures (approx. 2.0 × 109 CFU/mL) were mixed in 10 mL glass tubes with
500 µL of rat heparinized plasma from Sprague Dawley rats (Equitech-Bio, Kerrville, TX, USA) and
incubated at 37◦C without agitation. The coagulation state was visually examined in a blinded fashion
after 0.5 h, 1 h, 2 h, 3 h, 4 h, 5 h, 19 h and 24 h using a modified coagulation score [103]. No coagulation
was reported as 0, cloudiness of plasma as 1, small coagulation flakes as 2, a medium sized clot as 3,
a large clot as 4 and complete coagulation (tube can be inverted) as 5 [45].
5.9. Statistical Analyses
Categorical data were assessed by using Pearson’s Chi-squared test. p values of ≤0.05 were
considered statistically significant.
Differences in the coagulation potential between the groups (rat CC49 vs. human CC49; rat CC88
vs. human CC88; human CC49 vs. human CC88, rat CC49 vs. rat CC88) were statistically evaluated
per time point by a Kruskal-Wallis test with Dunn’s multiple comparisons test.
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